Clinical Trial Update: Effects of Botulinum Neurotoxin Type A (BoNT/A) Free of Complexing Proteins in the Spastic Equinovarus Foot [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating botulinum toxin type A free of complexing proteins for spastic equinovarus foot in stroke rehabilitation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• XEOMIN (INCOBOTULINUMTOXINA)

Snippet

Sponsor: Parc de Salut Mar | Conditions: Stroke Rehabilitation, Stroke Rehabilitation Spasticity Management | Phase 4 | Status: COMPLETED